Last reviewed · How we verify
NCT06009562: LPTM-UFs-P
Management of Symptomatic Uterine Fibroids in Pregnancy by Laparotomic Myomectomy: a Prospective Cohort Study
trial testing Laparotomic myomectomy during pregnancy in Uterine Fibroid in 28 participants. Status unknown.
19 August 2023
Quick facts
| Lead sponsor | University of Palermo |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 28 |
| Start date | 19 August 2023 |
| Primary completion | 19 August 2023 |
| Estimated completion | 1 January 2024 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- Laparotomic myomectomy during pregnancy
Conditions studied
- Uterine Fibroid — all drugs for Uterine Fibroid →
- Pregnancy Related — all drugs for Pregnancy Related →
Sponsor
University of Palermo
Who can join
Eligibility, female only, with Uterine Fibroid or Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The frequency of women presenting with a combination of uterine fibroids and pregnancy is in-creasing nowadays. Uterine fibroids in pregnancy are an unfavorable condition in themselves and being reactive to hormonal stimuli, tending to grow, can generate symptoms of different lev-els of severity. Obstetrics and gynecologists are increasingly faced with the problem of clarifying the management tactics of pregnant patients with symptomatic fibroids, who may see their preg-nancy put at risk by these masses.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Outcomes of Laparotomic Myomectomy during Pregnancy for Symptomatic Uterine Fibroids: A Prospective Cohort Study.
Babunashvili EL, Son DY, Buyanova SN, Schukina NA, et al · · 2023 · cited 10× · PMID 37835049 · DOI 10.3390/jcm12196406
Verify or expand the search:
- PubMed search for NCT06009562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Uterine Fibroid
Currently open trials in the same condition.
- NCT07173127 — The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemos · NA · recruiting
- NCT06705075 — Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE · Phase 2 · recruiting
- NCT06244251 — Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids · NA · active not recruiting
- NCT05386615 — Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids · recruiting
Other University of Palermo trials
Trials by the same sponsor.
- NCT03017716 — Inflammatory Back Pain and Gluten Free Diet · NA · not yet recruiting
- NCT07364149 — Acute Effects of Structured Exercise and Static Stretching on Vascular Function, Neuromuscular Performance, and Metaboli · NA · recruiting
- NCT06206616 — Liver Steatosis in Pediatric CD Patients · not yet recruiting
- NCT07433543 — Foam Rolling, Blood Pressure and Range of Motion · NA · completed
- NCT07213011 — Effects of Static Stretching and Self-myofascial Release on Local and Remote Range of Motion · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06009562 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Palermo
- Last refreshed: 24 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06009562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing